-
公开(公告)号:US10081681B2
公开(公告)日:2018-09-25
申请号:US15021102
申请日:2014-09-18
发明人: Alan J. Korman , Nils Lonberg , David J. Fontana , Andres A. Gutierrez , Mark J. Selby , Katherine E. Lewis
IPC分类号: C07K16/28 , A61K39/395 , A61K39/00
CPC分类号: C07K16/2818 , A61K2039/505 , A61K2039/507 , A61K2039/54 , A61K2039/545 , A61P35/00 , C07K16/2803 , C07K2317/21 , C07K2317/24 , C07K2317/53 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/94
摘要: Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody.
-
公开(公告)号:US11274152B2
公开(公告)日:2022-03-15
申请号:US17018241
申请日:2020-09-11
发明人: Alan J. Korman , Nils Lonberg , David J. Fontana , Andres A. Gutierrez , Mark J. Selby , Katherine Lewis
摘要: Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody.
-
公开(公告)号:US20200062845A1
公开(公告)日:2020-02-27
申请号:US16376394
申请日:2019-04-05
发明人: Alan J. Korman , Nils Lonberg , David J. Fontana , Andres A. Gutierrez , Mark J. Selby , Katherine Lewis
摘要: Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody.
-
-